159 related articles for article (PubMed ID: 28710427)
1. The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells.
Dabiri Y; Kalman S; Gürth CM; Kim JY; Mayer V; Cheng X
Sci Rep; 2017 Jul; 7(1):5423. PubMed ID: 28710427
[TBL] [Abstract][Full Text] [Related]
2. New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma.
Gomes S; Raimundo L; Soares J; Loureiro JB; Leão M; Ramos H; Monteiro MN; Lemos A; Moreira J; Pinto M; Chlapek P; Veselska R; Sousa E; Saraiva L
Cancer Lett; 2019 Apr; 446():90-102. PubMed ID: 30664963
[TBL] [Abstract][Full Text] [Related]
3. TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma.
Bae WK; Hong CS; Park MR; Sun EG; Lee JH; Kang K; Ryu KH; Shim HJ; Hwang JE; Cho SH; Chung IJ
Cancer Lett; 2018 Feb; 415():106-116. PubMed ID: 29222041
[TBL] [Abstract][Full Text] [Related]
4. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
5. CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer.
Malik N; Yan H; Yang HH; Ayaz G; DuBois W; Tseng YC; Kim YI; Jiang S; Liu C; Lee M; Huang J
PLoS Genet; 2021 May; 17(5):e1009553. PubMed ID: 33945523
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib Stabilizes and Activates p53 in Proliferative Compartments of Both Normal and Tumor Tissues
Xue Y; Barker N; Hoon S; He P; Thakur T; Abdeen SR; Maruthappan P; Ghadessy FJ; Lane DP
Cancer Res; 2019 Jul; 79(14):3595-3607. PubMed ID: 31138526
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor.
Wu T; Chen W; Zhong Y; Hou X; Fang S; Liu CY; Wang G; Yu T; Huang YY; Ouyang X; Li HQ; Cui L; Yang Y
Mol Cancer Ther; 2017 Apr; 16(4):717-728. PubMed ID: 27903750
[TBL] [Abstract][Full Text] [Related]
8. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
9. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
10. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
11. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
[TBL] [Abstract][Full Text] [Related]
12. Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
Abu El Maaty MA; Strassburger W; Qaiser T; Dabiri Y; Wölfl S
Mol Carcinog; 2017 Nov; 56(11):2486-2498. PubMed ID: 28618116
[TBL] [Abstract][Full Text] [Related]
13. Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.
Wang J; Xie H; Gao F; Zhao T; Yang H; Kang B
Tumour Biol; 2016 Mar; 37(3):4203-12. PubMed ID: 26490992
[TBL] [Abstract][Full Text] [Related]
14. Crocetin exploits p53-induced death domain (PIDD) and FAS-associated death domain (FADD) proteins to induce apoptosis in colorectal cancer.
Ray P; Guha D; Chakraborty J; Banerjee S; Adhikary A; Chakraborty S; Das T; Sa G
Sci Rep; 2016 Sep; 6():32979. PubMed ID: 27622714
[TBL] [Abstract][Full Text] [Related]
15. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53.
Song X; Dilly AK; Choudry HA; Bartlett DL; Kwon YT; Lee YJ
Mol Cancer Res; 2015 Dec; 13(12):1533-43. PubMed ID: 26354682
[TBL] [Abstract][Full Text] [Related]
17. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
18. p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality?
Wang C; Teo CR; Sabapathy K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079264
[TBL] [Abstract][Full Text] [Related]
19. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
[TBL] [Abstract][Full Text] [Related]
20. Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.
Kim IY; Park SY; Kang Y; Thapa D; Choi HG; Kim JA
Arch Pharm Res; 2011 Feb; 34(2):323-30. PubMed ID: 21380817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]